Gouk Warren
Known title: Chief Administrative OfficerCIK: 0001865503
Associated companies
Transaction History
| LFST | ▼ Sell | Open Market | 38,058 | $314K | 9/1/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 11,966 | $99K | 8/31/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 57,754 | $523K | 6/22/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 45,984 | $412K | 6/14/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 47,142 | $411K | 6/13/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 2,858 | $24K | 6/12/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 4,785 | $36K | 4/4/2023 | View on chart |
| LFST | ▲ Buy | Grant | 58,760 | $0 | 3/6/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 15,106 | $109K | 11/7/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 15,106 | $113K | 10/31/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 15,106 | $107K | 10/24/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 15,106 | $121K | 10/17/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 15,106 | $113K | 10/10/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 15,106 | $106K | 10/3/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 51,672 | $466K | 9/8/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 34,449 | $241K | 9/6/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 17,226 | $121K | 8/23/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 17,226 | $135K | 8/15/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 17,226 | $126K | 8/8/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 68,904 | $482K | 8/3/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 67,479 | $359K | 6/13/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 10,000 | $73K | 6/9/2022 | View on chart |
| LFST | ▲ Buy | Grant | 76,446 | $0 | 4/25/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Keybanc Raises LifeStance Health Price Target to $15
Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.
Keybanc Raises LifeStance Health Price Target to $15. Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.